Express News | Wedbush Reiterates Outperform on Tyra Biosciences, Maintains $28 Price Target
Moomoo 24/7Mar 21 08:47 ET
Express News | HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Raises Price Target to $23
Moomoo 24/7Mar 20 06:42 ET
Tyra Biosciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/20/2024 42.86% HC Wainwright & Co. $19 → $23 Reiterates Buy → Buy 12/29/2023 67.7% Wedbush $27 → $27 Re
BenzingaMar 20 06:41 ET
Tyra Biosciences Inc (TYRA) Reports Increased R&D Investments Amid Pipeline Progress
Yahoo FinanceMar 19 21:01 ET
Tyra Biosciences Inc Files For Resale Of Up To 15.4M Shares By The Selling Securityholders
Tyra Biosciences Inc Files For Resale Of Up To 15.4M Shares By The Selling Securityholders
BenzingaMar 19 17:00 ET
Tyra Biosciences Q4 Net Loss Widens
Tyra Biosciences (TYRA) reported a Q4 net loss late Tuesday of $0.53 per diluted share, compared with a loss of $0.31 per share a year earlier. Analysts polled by Capital IQ expected a loss of $0.48.
MT NewswiresMar 19 16:53 ET
Tyra Biosciences GAAP EPS of -$0.53 Misses by $0.05
Seeking AlphaMar 19 16:51 ET
Tyra Biosciences Files to Sell 15.37M Shares of Common Stock for Holders
Seeking AlphaMar 19 16:50 ET
Tyra Biosciences: Pro-forma Cash Position of About $403.5 M Expected to Support Clinical and Operational Milestones Through at Least 2026 >TYRA
Tyra Biosciences: Pro-forma Cash Position of About $403.5 M Expected to Support Clinical and Operational Milestones Through at Least 2026 >TYRA
Dow JonesMar 19 16:17 ET
Tyra Biosciences: Advanced SURF301 Phase 1 Oncology Study; Initial Phase 1 Results to Be Reported in 2H >TYRA
Tyra Biosciences: Advanced SURF301 Phase 1 Oncology Study; Initial Phase 1 Results to Be Reported in 2H >TYRA
Dow JonesMar 19 16:14 ET
Tyra Biosciences: TYRA-300 Phase 2 ACH IND Submission on Track for 2H
Tyra Biosciences: TYRA-300 Phase 2 ACH IND Submission on Track for 2H
Dow JonesMar 19 16:14 ET
Tyra Biosciences Strengthened Balance Sheet With About $200 M PIPE in 1Q
Tyra Biosciences Strengthened Balance Sheet With About $200 M PIPE in 1Q
Dow JonesMar 19 16:14 ET
Tyra Biosciences Q4 EPS $(0.53) Misses $(0.48) Estimate
Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.48) by 10.42 percent. This is a 70.97 percent decrease over losses of $
BenzingaMar 19 16:12 ET
Tyra Biosciences 4Q Loss/Shr 53c >TYRA
Tyra Biosciences 4Q Loss/Shr 53c >TYRA
Dow JonesMar 19 16:08 ET
Press Release: Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights
Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights PR Newswire CARLSBAD, Calif., March 19, 2024 - Advanced SURF301 Phase 1 oncology study; Initial Phase 1 r
Dow JonesMar 19 16:05 ET
TYRA BIOSCIENCES, INC.(TYRA.US) Officer Sells US$4,000 in Common Stocks
$TYRA BIOSCIENCES, INC.(TYRA.US)$ Officer Bensen Daniel sold 200 shares of Common Stocks on Mar 11, 2024 at an average price of $20 for a total value of $4,000.Source: Announcement What is statement o
moomoo NewsMar 13 18:28 ET
TYRA BIOSCIENCES, INC.(TYRA.US) Officer Sells US$36,179.44 in Common Stocks
$TYRA BIOSCIENCES, INC.(TYRA.US)$ Officer Bensen Daniel sold 1,801 shares of Common Stocks on Mar 6, 7, 2024 at an average price of $20.089 for a total value of $36,179.44.Source: Announcement What is
moomoo NewsMar 8 18:20 ET
Insider Sell: Tyra Biosciences Inc (TYRA) COO Daniel Bensen Sells 9,152 Shares
Yahoo FinanceMar 5 23:27 ET
TYRA BIOSCIENCES, INC.(TYRA.US) Officer Sells US$183.57K in Common Stocks
$TYRA BIOSCIENCES, INC.(TYRA.US)$ Officer Bensen Daniel sold 9,152 shares of Common Stocks on Mar 1, 4, 5, 2024 at an average price of $20.0577 for a total value of $183.57K.Source: Announcement What
moomoo NewsMar 5 18:23 ET
Insider Sell: Tyra Biosciences Inc (TYRA) COO Daniel Bensen Sells 8,644 Shares
Yahoo FinanceMar 1 00:40 ET
No Data
No Data